Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Karen, Quillen"'
Autor:
Priyamvada Singh, Hui Chen, Craig E. Gordon, Sandeep Ghai, J. Mark Sloan, Karen Quillen, Sara Moradi, Vipul Chitalia, Amitabh Gautam, Joel Henderson, Jean M. Francis
Publikováno v:
Kidney Medicine, Vol 1, Iss 3, Pp 139-143 (2019)
Eculizumab is an emerging therapy for atypical hemolytic uremic syndrome (aHUS). Early identification and treatment of recurrent aHUS after kidney transplantation requires a high clinical suspicion but results in improved graft function and patient o
Externí odkaz:
https://doaj.org/article/731970afc2ed48ad81f00a13e6aeffe2
Autor:
Rachel R. Yuen, Dylan Steiner, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Erika L. Smith, Lillia A. Baird, Filiz Korkmaz, Patricia Urick, Manish Sagar, Jacob L. Berrigan, Suryaram Gummuluru, Ronald B. Corley, Karen Quillen, Anna C. Belkina, Gustavo Mostoslavsky, Ian R. Rifkin, Yachana Kataria, Amedeo J. Cappione, Wenda Gao, Nina H. Lin, Nahid Bhadelia, Jennifer E. Snyder-Cappione
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The COVID-19 pandemic has drastically impacted work, economy, and way of life. Sensitive measurement of SARS-CoV-2 specific antibodies would provide new insight into pre-existing immunity, virus transmission dynamics, and the nuances of SARS-CoV-2 pa
Externí odkaz:
https://doaj.org/article/a872479249714dd78bd7bc72df044446
Autor:
Laith al-Rabadi, Karen Quillen, Moshe Shashar, Catreena Al Marji, Aala Jaberi, Vipul Chitalia, Joel Henderson, David Salant, Laurence H. Beck, Jr.
Publikováno v:
Kidney International Reports, Vol 3, Iss 2, Pp 476-481 (2018)
Externí odkaz:
https://doaj.org/article/c62cb60ada0a43d29f9e07f4226ce7a3
Autor:
Luke Zheng, Vaishali Sanchorawala, Dina Brauneis, J. Mark Sloan, Shayna Sarosiek, Karen Quillen
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 8, Pp 1-6 (2020)
Blood Cancer Journal
Blood Cancer Journal
Hematologic complete response (hemCR) in AL amyloidosis requires absence of monoclonal protein by immunofixation electrophoreses (IFE) and normal serum free light chain ratio (FLCR). Recent literature suggests that an involved free light chain (iFLC)
Autor:
Vishal K. Gupta, Vaishali Sanchorawala, J. Mark Sloan, Karen Quillen, Shayna Sarosiek, Anthony C Shelton, Dina Brauneis
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:e169-e173
In immunoglobulin light-chain (AL) amyloidosis, the depth of hematologic response to treatment is associated with improved survival and organ responses. We conducted a clinical trial using bortezomib in induction and in conditioning with melphalan be
Autor:
Ilyas Yambayev, Lina Ma, Artem Shevtsov, Qing Zhao, Murad Elsadwai, Eric J. Burks, Charitha Vadlamudi, Karen Quillen, Yachana Kataria, Tao Zuo, Hanqiao Zheng, Sara E Higgins, Emily Aniskovich, Michael Kritselis, Andrey Prilutskiy, Carmen Sarita-Reyes
Publikováno v:
Human Pathology
Objectives Severe COVID-19 results in a glucocorticoid responsive form of acute respiratory distress (ARDS)/diffuse alveolar damage (DAD). Herein we compare the immunopathology of lung tissue procured at autopsy in patients dying of SARS-CoV-2 with t
Publikováno v:
International Journal of Laboratory Hematology. 44:53-54
Autor:
Nahid Bhadelia, Wenda Gao, Anna C. Belkina, Amedeo Cappione, Jacob Berrigan, Erika L Smith, Elizabeth Chavez, Ian R. Rifkin, Patricia Urick, Gustavo Mostoslavsky, Jennifer E. Snyder-Cappione, Alex Olson, Filiz Korkmaz, Ronald B. Corley, Suryaram Gummuluru, Riley M.F. Pihl, Manish Sagar, L. Baird, Nina Lin, Dylan Steiner, Karen Quillen, Yachana Kataria, Rachel Yuen
The COVID-19 pandemic has significantly impacted work, economy, and way of life. The SARS-CoV-2 virus displays unique features including widely varying symptoms and outcomes between infected individuals. Sensitive measurement of SARS-CoV-2 specific a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c80d0defb215a3073ecb4af9d8ffd582
https://doi.org/10.1101/2020.09.15.20192765
https://doi.org/10.1101/2020.09.15.20192765
Autor:
Charitha Vadlamudi, J. Mark Sloan, Shayna Sarosiek, Ilyas Yambayev, Qing Zhao, Michael Kritselis, Artem Shevtsov, Eric J. Burks, Andrey Prilutskiy, Adam Lerner, Karen Quillen, Yachana Kataria
BackgroundA subset of COVID-19 patients exhibit clinical features of cytokine storm. However, clinicopathologic features diagnostic of hemophagocytic lymphohistiocytosis (HLH) have not been reported. Pathologic studies to date have largely focused on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27482288624a8e878808a44946077884
https://doi.org/10.1101/2020.05.07.20094888
https://doi.org/10.1101/2020.05.07.20094888
Autor:
Karen Quillen, Vaishali Sanchorawala, Amitabh Gautam, Jean Francis, Linda Pelletier, Yanli Ding
Publikováno v:
Clinical Nephrology. 89:252-259
Late occurrence of antibody-mediated rejection (AMR), defined as occurring 6 months after transplantation, is associated with poor renal allograft survival, compared to early acute AMR and acute cellular rejection. The proteasome inhibitor bortezomib